Back to Startups

SpyGlass Pharma

Bioscience & Disease Healthcare Systems
Bioscience & Disease Healthcare Systems Show less
Bioscience & Disease Healthcare Systems
Bioscience & Disease Healthcare Systems Show less
Website LinkedIn San Francisco, California, USA
About SpyGlass Pharma

SpyGlass Pharma is a biotechnology startup focused on developing innovative drug delivery solutions for chronic ophthalmic diseases. Their flagship product is the world's first intraocular lens (IOL)-mounted, controlled release drug delivery platform, designed to provide long-term therapy for glaucoma patients.

Business Information
Target Customers
healthcare providers ophthalmologists patients with glaucoma
Industry Categories
Bioscience & Disease Healthcare Systems
Business Model
Revenue Model Product sales
Pricing Strategy N/A
Sales Channels direct sales, partnerships with healthcare institutions
Funding Timeline
Round Date Amount Investors
Series D Jun 02, 2025 $75.0M Unknown
Founders

No founder information available.

Investors

No investor information available.

Recent Mentions
raisingfi
Raising.fi @raisingfi
Jun 02, 2025

New Raise 🏛️ Company: SpyGlass Pharma 🔗 Website: https://t.co/aPaZPzUhxC 📊 Amount: $75 Million 🔄 Round: Series D 🧮 Valuation: N/A ⚙️ Industry: Biotechnology, Healthcare

View on Twitter
Similar Startups
Glass Imaging
87% match

Glass Imaging is revolutionizing mobile photography by utilizing artificial intelligence to unlock t...
SpliceBio
86% match

SpliceBio is a genetic medicines company harnessing its proprietary Protein Splicing platform to dev...
IXI
85% match

Next generation of AR smart glasses
Longbio
85% match

Longbio Pharma is a biotech startup focused on developing innovative therapies for autoimmune and ra...